Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $44.3000 (3.63%) ($41.6000 - $44.6000) on Mon. May. 14, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.15% (three month average) | RSI | 64 | Latest Price | $44.3000(3.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -2.075% in a week (0% probabilities). VIXM(-14%) TLT(-14%) UUP(-11%) UNG(-5%) VXX(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.075% (StdDev 4.15%) | Hourly BBV | 0 () | Intraday Trend | 3.3% | | | |
|
5 Day Moving Average | $41.18(7.58%) | 10 Day Moving Average | $41.04(7.94%) | 20 Day Moving Average | $40.87(8.39%) | To recent high | -8.4% | To recent low | 26% | Market Cap | $3.292b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |